<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348371</url>
  </required_header>
  <id_info>
    <org_study_id>AlcoGut</org_study_id>
    <nct_id>NCT03348371</nct_id>
  </id_info>
  <brief_title>The Effects of Ethanol on Intestinal Permeability and Gut Hormones</brief_title>
  <official_title>The Effects of Orally Ethanol vs. Isoethanolaemic i.v. Infusion of Ethanol on Intestinal Permeability and Gut Hormones</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aime of this study is to envsitigate if ethanol has an incretin effect. This is done by
      administration of ethanol orally vs. an isoethanolaemic i.v. infusion of ethanol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">October 1, 2017</completion_date>
  <primary_completion_date type="Actual">October 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum insulin level</measure>
    <time_frame>2 month</time_frame>
    <description>difference in serum insulin level between the two administration forms</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Insulin Resistance</condition>
  <condition>Ethanol</condition>
  <condition>Incretin Effect</condition>
  <arm_group>
    <arm_group_label>Oral day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant receive ethanol orally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>i.v. infusion day</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participant receive ethanol in an i.v. infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ethanol</intervention_name>
    <description>The intervention is two different administrationforms of ethanol, orally and i.v.</description>
    <arm_group_label>Oral day</arm_group_label>
    <arm_group_label>i.v. infusion day</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Caucasian male between 20 and 50 years of age

          -  Body mass index (BMI) between 19 and 25 kg/m2

          -  Weekly alcohol intake of less than 14 units of alcohol (of 12 g)

          -  Normal fasting plasma glucose concentration (i.e. &lt;6 mmol/l) and normal glycated
             haemoglobin A1c (HbA1c) (i.e. ≤42 mmol/mol)

          -  Normal haemoglobin

          -  Informed consent

        Exclusion Criteria:

          -  First-degree relatives with diabetes and/or liver disease

          -  Liver disease or other alcohol-related diseases, diabetes mellitus

          -  Liver disease (serum ALAT and/or serum ASAT &gt;2 × normal values)

          -  Nephropathy (serum creatinine above normal range and/or albuminuria)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Amalie Lanng</investigator_full_name>
    <investigator_title>BA</investigator_title>
  </responsible_party>
  <keyword>Incretin effect</keyword>
  <keyword>Ethanol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

